Medical Device Product Development

Navigating Medical Device Design Control & Risk Management

Helping you navigate integrated design control and risk management, while providing complete visibility into the entire development process for your medical device.

Nick Schofield

Nick Schofield is a content creator for Cognition Corporation. A graduate of the University of Massachusetts Lowell, he has written for newspapers, the IT industry, and cybersecurity firms. In his spare time, he is writing, hanging out with his girlfriend and his cats, or geeking out over craft beer. He can be reached at nick.schofield@cognition.us.

Blog Feature

Thought Leadership

The Roles Substantial Equivalence and FDA’s Least Burdensome Provisions Play in Premarket Notification

By: Nick Schofield
March 19th, 2019

Premarket notification is an intricate process for medical device manufacturers to navigate. Levels of risk, assurances of safety and effectiveness, device type, intended use, and a whole manner of other factors can shift your submission from PMA to De Novo to 510(k) in the blink of an eye.

Read More

Share

Blog Feature

Thought Leadership

5 Methods of Risk Control for Life Science Products

By: Nick Schofield
March 14th, 2019

Of all the dynamic aspects of life science product development, risk management is one of the most important. From an organizational standpoint, controlling risks associated with your products protects your business interests; likewise, it ensures higher levels of care and safety for patients and users. When done in an iterative fashion from the start of development, thorough risk control can have significant impacts on your products, services, and organization.

Read More

Share

How to Approach Usability Engineering & Use Error Analysis

Learn how activities like Use Error Analysis can lead to more dynamic, impactful risk management.

Subscribe to the blog and get this guide for free

Blog Feature

Thought Leadership | Industry Updates

7 Takeaways from FDA’s “Clinical Data in Med Device Submissions” Guidance

By: Nick Schofield
March 12th, 2019

After February 21, 2019, new FDA requirements for clinical investigations went into effect. These requirements are intended to ensure clinical data quality and integrity, as well as to protect human subjects’ well-being and safety. As a way of keeping domestic and international premarket medical device submissions consistent for regulatory review, the new acceptance criteria take aim at very particular issues in the compliance process for clinical investigations.

Read More

Share

Blog Feature

Thought Leadership

Risk Control and Life Science Product Development: Influencing Factors and Guiding Principles

By: Nick Schofield
March 7th, 2019

Managing the risks of your life science product can be a complex task. Some risks must be assumed, while others need to be controlled, transferred, monitored, or designed out of the product entirely. Implementing risk controls to reduce and manage the impact of associated risks, as well as their probability of occurrence, is the most common approach manufacturers leverage in their design and development efforts.

Read More

Share

Blog Feature

Thought Leadership

Organizational Growth and Compliance in Life Science Industries

By: Nick Schofield
March 5th, 2019

For many life science organizations, long-term growth is a primary goal. Whether focused on greater stability, increased revenues, or more diverse product portfolios, the need for expansion can drive how a company thinks and operates. However, pushing to expand your business is not without its difficulties.

Read More

Share

Blog Feature

Thought Leadership | Industry Updates

FDA Pulse Check: February 2019

By: Nick Schofield
February 28th, 2019

FDA was very busy in February 2019. In our latest edition of our FDA Pulse Check series, we’ve highlighted some of the month’s key stories worth catching up on.

Read More

Share

Blog Feature

Thought Leadership

What’s Slowing Your Life Science Organization’s Growth?

By: Nick Schofield
February 21st, 2019

As your life science organization advances and begins to expand its teams and portfolios, opportunities for productive, long-term growth present themselves. However, these opportunities aren’t always realized to their fullest extent or are missed out on entirely. If you’re struggling to grow your life science company, what could be slowing you down? To answer this question, there are four key areas you should take care of: process maturity, people, planning, and product portfolio management.

Read More

Share

Blog Feature

Thought Leadership

7 Modern Risk Factors for Medical Devices

By: Nick Schofield
February 19th, 2019

The medical device industry is in a state of immense change. Powered by technology, there are now incredible opportunities to improve patient outcomes, offer new and dynamic treatments, and help your organization thrive as a result. However, this technological change brings with it a number of new and evolving risk factors specific to our modern landscape.

Read More

Share

Blog Feature

Thought Leadership

Top 5 Public Health Concerns Life Sciences Can Address

By: Nick Schofield
February 14th, 2019

Life science product development can sometimes be a niche enterprise, and for good reason—certain populations and conditions require specific solutions and treatments. Providing these can be a boon to both patient outcomes and your organization’s bottom line, as well as progressing that particular field of treatment.

Read More

Share